-
First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PET
Pouw, J. E. E., Hashemi, S. M. S., Huisman, M. C., Wijngaarden, J. E., Slebe, M., Oprea-Lager, D. E., Zwezerijnen, G. J. C., Vugts, D., Ulas, E. B., de Gruijl, T. D., Radonic, T., Senan, S., Menke-van der Houven van Oordt, C. W. & Bahce, I., 1 Feb 2024, In: Journal for Immunotherapy of Cancer. 12, 2, e007659.Research output: Contribution to journal › Article › Academic › peer-review
-
Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC
Ulas, E. B., Hashemi, S. M. S., Houda, I., Kaynak, A., Veltman, J. D., Fransen, M. F., Radonic, T. & Bahce, I., 1 Sept 2023, In: JTO Clinical and Research Reports. 4, 9, 100532.Research output: Contribution to journal › Article › Academic › peer-review
-
Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better?
Ulas, E. B. & Bahce, I., 18 Jul 2023, In: Translational Lung Cancer Research. 12, 7Research output: Contribution to journal › Editorial › Academic › peer-review
- All publications
